Ana I Tabar

Summary

Affiliation: Hospital Virgen del Camino
Country: Spain

Publications

  1. doi request reprint Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
    Ana I Tabar
    Department of Allergy, Hospital Virgen del Camino, Pamplona, Spain
    J Allergy Clin Immunol 127:57-63, 63.e1-3. 2011
  2. doi request reprint Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy
    Esozia Arroabarren
    Department of Allergy, Complejo Hospitalario Navarra, Pamplona, Spain
    Pediatr Allergy Immunol 26:34-41. 2015
  3. ncbi request reprint Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety
    Ana I Tabar
    Department of Allergy, Hospital Virgen del Camino, Pamplona, Spain
    Pediatr Allergy Immunol 19:67-75. 2008

Collaborators

  • Esozia Arroabarren
  • María J Alvarez-Puebla
  • Blanca E Garcia
  • Susana Echechipía
  • Koldo Cambra

Detail Information

Publications3

  1. doi request reprint Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
    Ana I Tabar
    Department of Allergy, Hospital Virgen del Camino, Pamplona, Spain
    J Allergy Clin Immunol 127:57-63, 63.e1-3. 2011
    ..Specific immunotherapy (SIT) duration for respiratory allergy is currently based on individual decisions...
  2. doi request reprint Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy
    Esozia Arroabarren
    Department of Allergy, Complejo Hospitalario Navarra, Pamplona, Spain
    Pediatr Allergy Immunol 26:34-41. 2015
    ..Subcutaneous immunotherapy (SCIT) discontinuation data in children remain scarce...
  3. ncbi request reprint Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety
    Ana I Tabar
    Department of Allergy, Hospital Virgen del Camino, Pamplona, Spain
    Pediatr Allergy Immunol 19:67-75. 2008
    ..Physicians judged the disease course as significantly better in the active treatment group. ASIT with the A. alternata extract was safe, with clinical improvements after one year of treatment...